Dakang Xu

6.3k total citations · 1 hit paper
89 papers, 4.4k citations indexed

About

Dakang Xu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dakang Xu has authored 89 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 38 papers in Immunology and 31 papers in Oncology. Recurrent topics in Dakang Xu's work include Immune Cell Function and Interaction (14 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Dakang Xu is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Dakang Xu collaborates with scholars based in Australia, China and United States. Dakang Xu's co-authors include Bryan R.G. Williams, Matthew R. Thompson, Xiangliang Yuan, Junping Liu, Peihua Ni, Michael P. Gantier, Kaiyue Wu, Xiaoyan Li, Mark A. Behlke and Die Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Dakang Xu

85 papers receiving 4.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment

2020 488 citations Xiangliang Yuan, Peihua Ni et al. Frontiers in Immunology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Dakang Xu	2.3k	1.4k	1.1k	905	437	89	4.4k
Francesca Zazzeroni	3.0k 1.3×	1.2k 0.8×	1.6k 1.4×	1.0k 1.1×	289 0.7×	96	5.3k
Xiaojian Wang	1.9k 0.8×	1.5k 1.0×	774 0.7×	929 1.0×	372 0.9×	104	3.8k
Álvaro González	1.8k 0.8×	1.6k 1.1×	978 0.9×	1.2k 1.4×	433 1.0×	114	4.6k
Jochen Heß	3.2k 1.4×	1.4k 1.0×	1.2k 1.1×	1.4k 1.5×	601 1.4×	125	5.8k
Andrew L. Doedens	1.6k 0.7×	2.5k 1.8×	1.4k 1.3×	1.0k 1.2×	261 0.6×	24	4.5k
Stéphane Plaisance	2.8k 1.2×	2.1k 1.4×	1.5k 1.3×	1.2k 1.3×	558 1.3×	48	5.9k
Paola Cappello	1.5k 0.7×	1.8k 1.2×	837 0.7×	1.6k 1.8×	295 0.7×	97	4.0k
Sundaram Ramakrishnan	2.9k 1.3×	973 0.7×	1.0k 0.9×	1.1k 1.2×	269 0.6×	128	4.9k
Latifa Bakiri	2.5k 1.1×	699 0.5×	799 0.7×	1.0k 1.1×	342 0.8×	79	4.2k

Countries citing papers authored by Dakang Xu

Since Specialization

Citations

This map shows the geographic impact of Dakang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dakang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dakang Xu more than expected).

Fields of papers citing papers by Dakang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dakang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dakang Xu. The network helps show where Dakang Xu may publish in the future.

Co-authorship network of co-authors of Dakang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dakang Xu. A scholar is included among the top collaborators of Dakang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dakang Xu. Dakang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Xin, Y. Z. Sun, Lijun Wang, et al.. (2025). Enhancing gastric cancer prognosis prediction via multi-step multi-modality ensemble survival modeling of HE-stained images and mIHC data. Computer Methods and Programs in Biomedicine. 270. 108971–108971.

Yang, Xiaobao, Danping Liu, Yujie Zhu, et al.. (2024). Identifying the Spatial Architecture That Restricts the Proximity of CD8+ T Cells to Tumor Cells in Pancreatic Ductal Adenocarcinoma. Cancers. 16(7). 1434–1434. 4 indexed citations

Yung, Mingo M. H., Xuan Yang, Fushun Chen, et al.. (2024). Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment. Experimental Hematology and Oncology. 13(1). 9 indexed citations

Leung, Leanne Lee, Xueyu Wang, Wai-Sun Chan, et al.. (2023). Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Molecular Cancer. 22(1). 4–4. 71 indexed citations

Chen, Zhen, Xuhan Liu, Fuyi Li, et al.. (2022). Systematic Characterization of Lysine Post-translational Modification Sites Using MUscADEL. Methods in molecular biology. 2499. 205–219. 1 indexed citations

Du, Yuzhang, Juanjuan Zheng, Yue Song, et al.. (2022). ATF3 Positively Regulates Antibacterial Immunity by Modulating Macrophage Killing and Migration Functions. Frontiers in Immunology. 13. 839502–839502. 16 indexed citations

Ying, Le, Feng Yan, Liang Yu, et al.. (2018). PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers. OncoImmunology. 7(6). e1433520–e1433520. 31 indexed citations

Cheng, Haibo, Yanan Gao, Bo Zhu, et al.. (2018). β-Elemene Synergizes With Gefitinib to Inhibit Stem-Like Phenotypes and Progression of Lung Cancer via Down-Regulating EZH2. Frontiers in Pharmacology. 9. 1413–1413. 36 indexed citations

Li, Xiaofang, Run Tian, Hugh Gao, et al.. (2017). Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients. Scientific Reports. 7(1). 16495–16495. 53 indexed citations

10.

Xu, Dakang, et al.. (2016). Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat. Molecular Cancer Therapeutics. 15(7). 1726–1739. 12 indexed citations

11.

Yu, Liang, Junhua Li, Guohua Xie, et al.. (2013). ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton. Cancer Research. 73(12). 3625–3637. 8 indexed citations

12.

Thompson, Matthew R., Dakang Xu, & Bryan Williams. (2013). Activating Transcription Factor 3 Contributes to Toll-Like Receptor-Mediated Macrophage Survival via Repression of Bax and Bak. Journal of Interferon & Cytokine Research. 33(11). 682–693. 9 indexed citations

13.

Irving, Aaron T., Die Wang, Olivier Latchoumanin, et al.. (2012). Regulation of Actin Dynamics by Protein Kinase R Control of Gelsolin Enforces Basal Innate Immune Defense. Immunity. 36(5). 795–806. 37 indexed citations

14.

Xu, Dakang, et al.. (2009). Forecasting acute hypotensive episodes in intensive care patients based on a peripheral arterial blood pressure waveform. 545–548. 31 indexed citations

15.

Xu, Dakang, Michelle Holko, Anthony J. Sadler, et al.. (2009). Promyelocytic Leukemia Zinc Finger Protein Regulates Interferon-Mediated Innate Immunity. Immunity. 30(6). 802–816. 86 indexed citations

16.

Thompson, Matthew R., Dakang Xu, & Bryan R.G. Williams. (2009). ATF3 transcription factor and its emerging roles in immunity and cancer. Journal of Molecular Medicine. 87(11). 1053–1060. 282 indexed citations

17.

Li, He, Dakang Xu, Jinhua Li, Michael C. Berndt, & Junping Liu. (2006). Transforming Growth Factor β Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene. Journal of Biological Chemistry. 281(35). 25588–25600. 92 indexed citations

18.

Li, He, Dakang Xu, Ban‐Hock Toh, & Junping Liu. (2006). TGF-β and cancer: Is Smad3 a repressor of hTERT gene?. Cell Research. 16(2). 169–173. 34 indexed citations

19.

Qi, Sihua, et al.. (2005). Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. Transplantation Proceedings. 37(1). 150–154. 3 indexed citations

20.

Pritchard, Melanie, et al.. (2004). Tissue-specific overexpression of the HSA21 gene GABPα: implications for DS. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1739(1). 81–87. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact